Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01519219 · ClinicalTrials.gov registry record
Assessment Of Liver Function in Patients Undergoing Hepatic Irradiation
A clinical trial, sponsored by University of Michigan Rogel Cancer Center.
- Completed
- Registry status
- 208
- Enrollment target
NCT01519219: Completed study, sponsored by University of Michigan Rogel Cancer Center.
NCT01519219 is a clinical trial that has completed, run by University of Michigan Rogel Cancer Center. The registered enrollment target is 208 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01519219 has completed, sponsored by University of Michigan Rogel Cancer Center.
- COMPLETED
- Registry status
- 208 participants
- Enrollment target
Study Summary
The goal of the trial is to assess the effect of radiation treatment on liver function as determined by indocyanine green extraction. The long term goal is to determine if individual assessment of liver function using the IC-Green method, either alone or in combination with other factors, will provide Radiation Induced Liver Disease (RILD) risk-estimates that are superior to the probabilistic method currently in use.
Primary Outcome
Most subjects will have five IC-GREEN assessments. Graphical displays will be used to choose the form of a time-dependent model of IC-GREEN elimination. A mixed, possibly nonlinear model, with patient as random effect, will be fit to the data by the maximum likelihood principle. Profile confidence intervals for the parameters will be determined.
Interventions
- RADIATION Hepatic Irradiation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 208 participants |
| Start Date | 2004-11-24 |
| Est. Completion | 2020-02-19 |
What the finished NCT01519219 record still lists
NCT01519219 is an observational study that tracks outcomes without assigning an intervention. The registered 208 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Hepatic Irradiation is the first listed.
NCT01519219 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01519219 about?
NCT01519219 is a clinical study titled "Assessment Of Liver Function in Patients Undergoing Hepatic Irradiation". The goal of the trial is to assess the effect of radiation treatment on liver function as determined by indocyanine green extraction. The long term goal is to determine if individual assessment of liver function using the IC-Green method, either alone or in combination with other factors, will provi...
What is the current status of trial NCT01519219?
This trial is currently completed. The enrollment target is 208 participants. The study started on 2004-11-24. Estimated completion is 2020-02-19.
What interventions are being tested in trial NCT01519219?
The interventions under investigation include: Hepatic Irradiation (RADIATION).
Who is sponsoring clinical trial NCT01519219?
This trial is sponsored by University of Michigan Rogel Cancer Center, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03465774 · 208 participants
Indwelling Pleural Catheters With or Without Doxycycline in Treating Patients With Malignant Pleural Effusions
- NCT03803332 · 208 participants · NA
A Trial Comparing Interpersonal Therapy to Exposure Therapy for PTSD Due to Military Sexual Trauma (MST) in Male and Female Military Personnel
- NCT04732065 · 208 participants · Phase 1
ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors
- NCT05293756 · 208 participants · NA
OPtimizing Technology to Improve Medication Adherence and BP Control (OPTIMA-BP)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI